Webinar – Managing a team and patients during a pandemic

A keynote on managing a team and patients during a pandemic. By Celia Oreja-Guevara.

ABSTRACT

This video interview is based on the slide deck “Telemedicine in Multiple Sclerosis” by Mona Alkhawajah and Carlo Pozzilli. Dr Alkhawajah brings out the key points. 

‘Telemedicine’ infers the use of digital technologies to deliver healthcare services to patients at a distance. While telemedicine was previously considered an interesting concept to save on time and resources, its importance was quickly seen with the COVID-19 pandemic, where the medical community was obliged to find ways to improve the quality and efficiency of healthcare service provision while minimising the risk of disease transmission.

In this presentation, Drs Mona Alkhawajah and Carlo Pozzilli cover all the important aspects of telemedicine. By looking back on the history of telemedicine, they project us forward to its potential role in the care of the multiple sclerosis (MS) patient. A thorough analysis is provided of new applications for telemedicine, issues that need to be considered when implementing this technology, what the challenges are, and how they can be overcome.

BIOGRAPHY

MONA ALKHAWAJAH
Dr. Mona Alkhawajah is currently a Consultant Neurologist at the Neurosciences Department of King Faisal Specialist Hospital and Research Center, Riyadh (KFSHRC-R), and is an Assistant Professor at Al Faisal University. . She has been the Program Director of the Neurology Residency Training Program at KFSHRC-R for almost 5 years. Dr. Mona Alkhawajah received her Medical Degree from King Saud University, Riyadh. She then pursued her residency training in Neurology at KFSHRC-R. After obtaining her Saudi Board in Neurology, she completed her Fellowship in Neuroimmunology at the University of British Columbia, in Vancouver, Canada. That was followed by another fellowship in Neuromuscular Diseases at Vancouver General Hospital. Dr. Alkhawajah is currently conducting several research projects in the field of MS. She has established the first Multiple Sclerosis support group in the Kingdom, the first meeting took place in June 2014. She is the organizer of the first (2015) and second (2017) walk for MS in Saudi Arabia, and is actively involved in educating the public about MS through conferences and media. 

ABSTRACT

MANAGEMENT DURING A PANDEMIC

Prof Celia Oreja-Guevara concluded the e-workshop with an interesting keynote about managing a team and your patients during a pandemic.

This workshop was made possible with the support of Merck.

BIOGRAPHY

CELIA OREJA-GUEVARA
Professor Celia Oreja-Guevara is Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid and Professor of Neurology at the University Complutense, Madrid, Spain. After receiving her MD from the University Complutense, Madrid, Professor OrejaGuevara completed a PhD in neuroimmunology at the Max-Planck-Institute for Neurobiology, University of Munich, Munich (Germany). She then went on to complete a residency in the Department of Neurology at the University of Bochum, Bochum (Germany) and a postdoctoral fellowship in neuroimaging at the University Hospital San Raffaele, Milan (Italy). She has also held posts at the University of Düsseldorf (Germany),Hospital de Fuenlabrada and at the University Hospital La Paz, both in Madrid. Professor Oreja-Guevara’s research interests centre on clinical and neuroimaging correlations in MS and the use of optical coherence tomography. Neuromyelitis optica (NMO) is among her other therapy areas of interest, and Professor OrejaGuevara is actively involved in the evaluation of new drugs for the treatment of MS and NMO. As an investigator, she has participated in a number of MS clinical trials and currently heads the Neuroimaging Group of the Spanish Neurological Society, and she is a member of the Scientific Committee of the European Academy of Neurology. Currently, Professor Oreja-Guevara is an expert for the Spanish Medicines Agency and for the Scientific Advisory Group on Neurology of the European Medicines Agency


Media

Details

  • Directors

    ParadigMS
  • Author(s)

    Prof Celia Oreja-Guevara
  • Country

    Online
  • Release Date

    November 21, 2020
  • Views


You Might Also Like

Presentation – MRI and MS diagnosis and differential diagnosis

Presentation – MRI and the patient journey

Presentation – New MRI techniques and alternative “metrics” of MS

Article – Microbiome in Multiple Sclerosis

Presentation – Clinical outcome measures from trials explained

Presentation – MS Genetics

Article – An overview of pregnancy-related issues in patients with multiple sclerosis

Article – Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice


Educational slide decks
endorsed by experts

Minimum two MS experts collaborate to produce an educational slide deck. These slide decks are presented (live) to ParadigMS members, peer reviewed and updated.
The slide decks are published on the ParadigMS website “on behalf of ParadigMS”.

Consensus publications

Based on the slide decks, publications are produced. These publications are peer reviewed and published as consensus publications.

Regional and national educational events

Regional (fe: Scandinavian countries, Benelux, …) or national events where state-of-the-art science is transferred to general neurologists and other care givers (nurses, etc) that are confronted with MS in their day to day practice.

Web-based educational tools and resources

Webinars can complement the educational events.

Medical education (ME) programs

The educational slide decks, events and webinars can be important building blocks of accredited educational programs.

FAQs

Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.

Terms and Conditions

All the Terms and Conditions of the ParadigMS Foundation Website can be downloaded here.

Subscribe to our bi-annual Newsletter

ParadigMS does not send eNewsletters that contain advertisements and we do not share your contact details with sponsors (unless we received your explicit consent)